ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 78 filers reported holding ADAMAS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $704,000 | -65.1% | 146,750 | -54.9% | 0.00% | -66.7% |
Q2 2019 | $2,018,000 | -72.1% | 325,417 | -68.0% | 0.00% | -72.7% |
Q1 2019 | $7,238,000 | +76.6% | 1,017,983 | +112.1% | 0.01% | +83.3% |
Q4 2018 | $4,098,000 | -18.3% | 479,899 | +91.6% | 0.01% | 0.0% |
Q3 2018 | $5,015,000 | -43.3% | 250,495 | -26.8% | 0.01% | -50.0% |
Q2 2018 | $8,839,000 | +352.1% | 342,180 | +318.2% | 0.01% | +300.0% |
Q1 2018 | $1,955,000 | -91.2% | 81,820 | -87.5% | 0.00% | -90.3% |
Q4 2017 | $22,269,000 | -16.6% | 657,083 | -47.9% | 0.03% | -24.4% |
Q3 2017 | $26,686,000 | +352.2% | 1,260,579 | +273.6% | 0.04% | +272.7% |
Q2 2017 | $5,901,000 | -23.9% | 337,376 | -23.9% | 0.01% | -21.4% |
Q1 2017 | $7,754,000 | -15.0% | 443,067 | -17.9% | 0.01% | -26.3% |
Q4 2016 | $9,123,000 | -22.5% | 539,849 | -24.7% | 0.02% | -5.0% |
Q3 2016 | $11,772,000 | +39.7% | 717,375 | +28.9% | 0.02% | +5.3% |
Q2 2016 | $8,426,000 | +4071.3% | 556,569 | +3877.8% | 0.02% | +1800.0% |
Q1 2016 | $202,000 | -98.1% | 13,992 | -96.3% | 0.00% | -95.5% |
Q4 2015 | $10,570,000 | +1079.7% | 373,240 | +597.0% | 0.02% | +1000.0% |
Q3 2015 | $896,000 | +93.5% | 53,551 | +203.1% | 0.00% | +100.0% |
Q2 2015 | $463,000 | -40.9% | 17,668 | -60.5% | 0.00% | 0.0% |
Q1 2015 | $783,000 | +267.6% | 44,755 | +265.2% | 0.00% | – |
Q4 2014 | $213,000 | – | 12,255 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|